title: [New molecular target therapy for thyroid neoplasms and malignant melanomas].
authors.forename: Susumu
authors.initials: S
authors.lastname: Okano
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics; D058990:Molecular Targeted Therapy; D009536:Niacinamide / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077594:Nivolumab; D010671:Phenylurea Compounds / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics; D000077157:Sorafenib; D013449:Sulfonamides / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000235:genetics; D000077484:Vemurafenib
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D007211:Indoles; D000074324:Ipilimumab; D010671:Phenylurea Compounds; D011804:Quinolines; D013449:Sulfonamides; D000077484:Vemurafenib; D009536:Niacinamide; D000077594:Nivolumab; D000077157:Sorafenib; C531958:lenvatinib